Globus Medical (GMED) Reaches $37.00 52-Week High; Cna Financial (CNA)’s Sentiment Is 1.29

November 14, 2017 - By Neil V. Hobbs

CNA Financial Corporation is an insurance holding company. The company has market cap of $14.69 billion. The Company’s divisions include Specialty, Commercial, International, Life & Group Non-Core, and Corporate & Other Non-Core. It has a 16.05 P/E ratio. The Company’s Specialty segment provides a range of professional, financial, and specialty property, and casualty services and products.

The stock of Globus Medical Inc (NYSE:GMED) hit a new 52-week high and has $40.33 target or 9.00% above today’s $37.00 share price. The 8 months bullish chart indicates low risk for the $3.57 billion company. The 1-year high was reported on Nov, 14 by Barchart.com. If the $40.33 price target is reached, the company will be worth $321.30M more. About 25,025 shares traded. Globus Medical Inc (NYSE:GMED) has risen 30.88% since November 14, 2016 and is uptrending. It has outperformed by 14.18% the S&P500.

Analysts await Globus Medical Inc (NYSE:GMED) to report earnings on February, 26. They expect $0.34 EPS, up 9.68% or $0.03 from last year’s $0.31 per share. GMED’s profit will be $32.81M for 27.21 P/E if the $0.34 EPS becomes a reality. After $0.30 actual EPS reported by Globus Medical Inc for the previous quarter, Wall Street now forecasts 13.33% EPS growth.

Investors sentiment increased to 1.57 in 2017 Q2. Its up 0.21, from 1.36 in 2017Q1. It improved, as 25 investors sold Globus Medical Inc shares while 58 reduced holdings. 37 funds opened positions while 93 raised stakes. 62.65 million shares or 2.09% less from 63.99 million shares in 2017Q1 were reported. Schroder Invest Group Inc reported 0.02% stake. First Interstate Bancshares has 0.01% invested in Globus Medical Inc (NYSE:GMED) for 746 shares. Plante Moran Advsrs Lc has 0% invested in Globus Medical Inc (NYSE:GMED). Sio Capital Mngmt Ltd Liability Company has 113,400 shares for 1.79% of their portfolio. Mckinley Cap Management Limited Liability Corporation Delaware holds 0% or 340 shares. Pier Cap Ltd Liability Corp has 93,498 shares. Price T Rowe Assoc Md owns 0% invested in Globus Medical Inc (NYSE:GMED) for 18,603 shares. Parametric Portfolio Associate Ltd Liability reported 99,657 shares. Winfield Associates holds 0% or 120 shares in its portfolio. Louisiana State Employees Retirement Sys owns 18,800 shares or 0.03% of their US portfolio. Teachers Retirement Of The State Of Kentucky stated it has 0.03% of its portfolio in Globus Medical Inc (NYSE:GMED). Btim Corp holds 378,883 shares or 0.2% of its portfolio. Fdx Advsr Inc accumulated 16,546 shares or 0.02% of the stock. 1,615 are held by Qs Invsts Ltd Liability. Guggenheim Lc invested 0% of its portfolio in Globus Medical Inc (NYSE:GMED).

Among 15 analysts covering Globus Medical Inc (NYSE:GMED), 8 have Buy rating, 2 Sell and 5 Hold. Therefore 53% are positive. Globus Medical Inc had 38 analyst reports since August 3, 2015 according to SRatingsIntel. The stock has “Underperform” rating by Bank of America on Friday, January 8. The rating was maintained by Piper Jaffray on Tuesday, July 18 with “Buy”. On Tuesday, September 19 the stock rating was maintained by Canaccord Genuity with “Buy”. Piper Jaffray maintained the stock with “Buy” rating in Thursday, August 17 report. The rating was downgraded by Leerink Swann to “Market Perform” on Wednesday, July 27. As per Friday, November 10, the company rating was upgraded by Bank of America. On Thursday, August 3 the stock rating was maintained by Barclays Capital with “Underweight”. The stock of Globus Medical Inc (NYSE:GMED) earned “Buy” rating by Canaccord Genuity on Wednesday, November 8. Leerink Swann upgraded the shares of GMED in report on Wednesday, April 12 to “Outperform” rating. The firm earned “Equalweight” rating on Wednesday, July 27 by Barclays Capital.

Globus Medical, Inc. is a medical device company. The company has market cap of $3.57 billion. The Firm is focused on developing products for patients with musculoskeletal disorders. It has a 33.58 P/E ratio. It is focused on products to treat patients with spine disorders.

Loews Corp holds 76.47% of its portfolio in Cna Financial Corp for 242.65 million shares. Bislett Management Llc owns 200,000 shares or 5.94% of their US portfolio. Moreover, Pacifica Capital Investments Llc has 5.08% invested in the company for 203,388 shares. The California-based Private Management Group Inc has invested 3.24% in the stock. Towle & Co, a Missouri-based fund reported 458,735 shares.

Analysts await Cna Financial Corp (NYSE:CNA) to report earnings on February, 5. They expect $0.78 EPS, down 4.88% or $0.04 from last year’s $0.82 per share. CNA’s profit will be $211.52 million for 17.36 P/E if the $0.78 EPS becomes a reality. After $0.58 actual EPS reported by Cna Financial Corp for the previous quarter, Wall Street now forecasts 34.48% EPS growth.

About 2,760 shares traded. Cna Financial Corp (CNA) has risen 43.26% since November 14, 2016 and is uptrending. It has outperformed by 26.56% the S&P500.

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.

Twitter Auto Publish Powered By : XYZScripts.com